HomeKNTPF • OTCMKTS
add
Kintor Pharmaceutical Ltd
Previous close
$0.26
Year range
$0.11 - $0.36
Market cap
1.05B HKD
Avg Volume
43.00
P/E ratio
-
Dividend yield
-
Primary exchange
HKG
Market news
Financials
Income Statement
Revenue
Net income
(CNY) | Jun 2025info | Y/Y change |
---|---|---|
Revenue | 2.99M | — |
Operating expense | 40.45M | 11.72% |
Net income | -41.63M | -16.47% |
Net profit margin | -1.39K | — |
Earnings per share | — | — |
EBITDA | -34.62M | -6.41% |
Effective tax rate | 0.33% | — |
Balance Sheet
Total assets
Total liabilities
(CNY) | Jun 2025info | Y/Y change |
---|---|---|
Cash and short-term investments | 52.86M | -84.16% |
Total assets | 391.90M | -47.01% |
Total liabilities | 175.89M | -49.45% |
Total equity | 216.00M | — |
Shares outstanding | 434.07M | — |
Price to book | 0.52 | — |
Return on assets | -25.86% | — |
Return on capital | -33.41% | — |
Cash Flow
Net change in cash
(CNY) | Jun 2025info | Y/Y change |
---|---|---|
Net income | -41.63M | -16.47% |
Cash from operations | -34.76M | 37.18% |
Cash from investing | 7.37M | 2,266.47% |
Cash from financing | -20.03M | -169.18% |
Net change in cash | -47.28M | 24.26% |
Free cash flow | -18.67M | -6.37% |
About
CEO
Founded
2009
Website
Employees
136